RheOx® System - Galvanize Therapeutics®
Skip to the content
Products
RheOx® System

RheOx® System

RheOx is a minimally invasive bronchoscopic therapy designed to treat the underlying abnormal mucus-producing cells associated with chronic bronchitis symptoms. Using non-thermal Pulsed Electric Field (PEF) energy, RheOx reduces these abnormal cells while preserving airway structure, allowing healthier tissue to regenerate.

Disclaimer: The RheOx system is an investigational device in the United States. Limited by Federal law to investigational use.

 
View Clinical Evidence

The RheOx system for the treatment of the symptoms of chronic bronchitis consists of a proprietary electrosurgical generator and a single-use catheter. The minimally-invasive bronchoscopic therapy delivers short bursts of Pulsed Electric Field (PEF) energy to induce non-thermal ablation of the abnormal mucus-producing cells in the airways, leaving the extracellular matrix intact so that the epithelium may rapidly regenerate.

Disclaimer: The RheOx system is an investigational device in the United States. Limited by Federal law to investigational use.

Illustration of the RheOx catheter positioned in an airway

Bronchial rheoplasty procedure using the RheOx System

play

Pre- and post-treatment bronchoscopic images from a study patient.

Note the thick mucus before treatment, with resolution after treatment.

 

Bronchoscopic image of a study patient's airway before the procedure

Pre-treatment

 

Bronchoscopic image of the same airway one month after the procedure

1 month after treatment with
the RheOx System

Disclaimer: The RheOx system is an investigational device in the United States. Limited by Federal law to investigational use.

Clinical Evidence

Initial studies with the RheOx system showed technical feasibility and clinically meaningful improvements in the patients’ quality of life, with a favorable safety profile.

Improved quality of life1

1 .9 point

Reduction in CAT score*

1 .6 point

Reduction in SGRQ score*

 

*12 month results
CAT = COPD Assessment Test
SGRQ = St. George’s Respiratory Questionnaire​

1. Valipour A, Fernandez-Bussy S, Ing AJ, et al. Bronchial rheoplasty for treatment of chronic bronchitis. Twelve-month results from a multicenter clinical trial. Am J Respir Crit Care Med. 2020;202(5):681-689. doi:10.1164/rccm.201908-1546OC

Patient stories

Chronic bronchitis is a chronic disease that drastically impacts a person’s quality of life. Watch the inspiring stories of real patients living with chronic bronchitis. Learn about their diagnosis, treatment, and journey to regaining their quality of life.

Request Information

"*" indicates required fields

Important Notice:

Galvanize Therapeutics® is a medical device manufacturer, not a healthcare provider. The information submitted through this form will be used solely to connect you with a physician in your area who uses the Aliya® PEF System. Please do not submit protected health information (PHI) — including diagnosis, treatment history, or medical records — through this form.

The Aliya® PEF System (K212871, K233884, and K253826) is 510(k) cleared in the United States for the surgical ablation of soft tissue. Galvanize Therapeutics® does not promote the off-label use of its products and nothing herein is intended to promote an off-label use of the Aliya PEF System. The Aliya PEF System is a tool for the surgical ablation of soft tissue it is not intended to treat, cure, prevent, nor mitigate any specific disease or condition.

For questions about coverage or eligibility for this procedure, please consult your physician and insurance provider.

I Understand